Elite Pharmaceuticals (ELTP) Net Margin (2010 - 2026)
Elite Pharmaceuticals (ELTP) reported Net Margin of 18.27% for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 32.90 percentage points from -14.63% a year earlier but down 27.04 percentage points from the prior quarter.
Elite Pharmaceuticals (ELTP) Net Margin (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Elite Pharmaceuticals' Net Margin came in at 40.19%, up 50.44 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it came in at 30.14%, up 35.28 percentage points from FY2025.
- Net Margin has a five-year change of +10.09 percentage points (FY2021 to FY2026).
- By fiscal year, Net Margin came in at -5.13% in FY2025 (-40.65 pp), 35.51% in FY2024 (+25.08 pp), 10.43% in FY2023 (-17.15 pp) and 27.58% in FY2022 (+7.53 pp).
- Five-year quarterly Net Margin spans a low of -75.83% in fiscal Q3 2025 and a high of 105.49% in fiscal Q2 2024.
- Year over year, Net Margin gained in four of the last eight quarters, with an average year-over-year change of +3.54 percentage points.
- The high point for year-over-year Net Margin in five years was fiscal Q3 2026 (a gain of 134.69 percentage points); the low point was fiscal Q2 2025 (a drop of 163.94 percentage points).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at 45.31% (Q4 2026), 58.86% (Q3 2026) and 37.73% (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.82 Bn | 1,105.41 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 617.41 Bn | 535.94 Bn | 17.26 Bn | 21.86% |
| 3 | AbbVie | 501.29 Bn | 474.40 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 368.15 Bn | 322.53 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 297.07 Bn | 261.06 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 260.90 Bn | 234.58 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 236.34 Bn | 191.74 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 191.00 Bn | 165.20 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 169.72 Bn | 116.36 Bn | 10.94 Bn | -1.65% |
| 10 | Elite Pharmaceuticals | 268.12 Mn | 149.80 Mn | 13.51 Mn | 18.27% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.27% |
| Mar 31, 2026 | 45.31% |
| Dec 31, 2025 | 58.86% |
| Sep 30, 2025 | 37.73% |
| Jun 30, 2025 | -14.63% |
| Mar 31, 2025 | 53.12% |
| Dec 31, 2024 | -75.83% |
| Sep 30, 2024 | -58.45% |
| Jun 30, 2024 | 3.27% |
| Mar 31, 2024 | 18.53% |
| Dec 31, 2023 | 4.55% |
| Sep 30, 2023 | 105.49% |
| Jun 30, 2023 | 12.71% |
| Mar 31, 2023 | -20.72% |
| Dec 31, 2022 | 36.14% |
| Sep 30, 2022 | 25.66% |
| Jun 30, 2022 | 3.99% |
| Mar 31, 2022 | 31.66% |
| Dec 31, 2021 | 25.44% |
| Sep 30, 2021 | 21.00% |
Elite Pharmaceuticals Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();